You are here: Industry Insights > Diabetes

News List

Abbott and Novo Nordisk enter partnership to provide integrated digital solution to people with diabetes using insulin worldpharmanews
February 21, 2019
Abbott and Novo Nordisk today announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk...
FDA Authorizes First Interoperable Insulin Pump americanpharmaceuticalreview
February 18, 2019
The U.S. Food and Drug Administration (FDA) permitted marketing of the Tandem Diabetes Care t:Slim X2 insulin pump with interoperable technology (interoperable t:Slim X2) for delivering insulin under the skin for children and adults with diabetes....
Pharma companies clear the R&D decks in Q4 pharmaphorum
February 13, 2019
The fourth-quarter results season has already seen a host of unwanted projects cleared from pharma companies’ pipelines as they tighten their focus on the projects with the most chance of a good return on investment.
Doctors Should Encourage Exercise in Patients With Diabetes, CV Disease drugs
January 24, 2019
Physicians need to take an active role in prescribing specific exercise training in patients with both type 2 diabetes mellitus and cardiovascular disease, according to ....
Insulin Price More Than Doubled in the United States drugs
January 24, 2019
Some Americans with type 1 diabetes have cut back on their insulin usage as the cost of the drug nearly doubled over a five-year period.....
Poor Glycemic Control in Type 1 Diabetes Tied to Fracture Risk drugs
January 23, 2019
Poor glycemic control is associated with an increased risk for fracture in patients with type 1 diabetes mellitus (T1DM) but not in patients with type 2 diabetes mellitus (T2DM)...
Center for Beta Cell Therapy in Diabetes, ViaCyte Announce Start of European Clinical Trial of Human Stem Cell-derived Implants americanpharmaceuticalreview
January 23, 2019
The Center for Beta Cell Therapy in Diabetes and ViaCyte announced a human stem cell-derived product candidate has been implanted in type 1 diabetes patients at a subtherapeutic dose.....
Daiichi Sankyo takes option on diabetes stem cell start-up pharmaphorum
January 14, 2019
Japan’s Daiichi Sankyo has joined an open innovation research initiative that will try to develop a therapy for type 1 diabetes based on insulin-producing cells.
Canagliflozin may not be associated with fracture risk in diabetes patients europeanpharmaceuticalreview
January 03, 2019
A study has found that when compared with other drugs, canagliflozin may not be associated with fractures in patients with diabetes…
Novo taps e-therapeutics for diabetes target discovery drive fiercebiotech
December 28, 2018
Novo Nordisk has enlisted e-therapeutics to support target discovery efforts at its recently-opened research center in Oxford, U.K. .....